SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-17-002085
Filing Date
2017-04-12
Accepted
2017-04-12 12:11:50
Documents
4
Period of Report
2017-05-24
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_041217.htm DEF 14A 747274
2 GRAPHIC logo.jpg GRAPHIC 6569
3 GRAPHIC proxy_01.jpg GRAPHIC 126594
4 GRAPHIC proxy_02.jpg GRAPHIC 81527
  Complete submission text file 0001171843-17-002085.txt   1044272
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 17757425
SIC: 2836 Biological Products, (No Diagnostic Substances)